Riken Keiki Co., Ltd.

TSE:7734 Voorraadrapport

Marktkapitalisatie: JP¥195.8b

Riken Keiki Toekomstige groei

Future criteriumcontroles 3/6

Riken Keiki is forecast to grow earnings and revenue by 14.5% and 8.4% per annum respectively. EPS is expected to grow by 14.5% per annum. Return on equity is forecast to be 14.2% in 3 years.

Belangrijke informatie

14.5%

Groei van de winst

14.5%

Groei van de winst per aandeel

Electronic winstgroei12.7%
Inkomstengroei8.4%
Toekomstig rendement op eigen vermogen14.2%
Dekking van analisten

Low

Laatst bijgewerkt03 Sep 2024

Recente toekomstige groei-updates

Recent updates

Investors Will Want Riken Keiki's (TSE:7734) Growth In ROCE To Persist

Oct 21
Investors Will Want Riken Keiki's (TSE:7734) Growth In ROCE To Persist

Riken Keiki Co., Ltd. (TSE:7734) Not Lagging Market On Growth Or Pricing

Sep 20
Riken Keiki Co., Ltd. (TSE:7734) Not Lagging Market On Growth Or Pricing

Estimating The Fair Value Of Riken Keiki Co., Ltd. (TSE:7734)

Sep 04
Estimating The Fair Value Of Riken Keiki Co., Ltd. (TSE:7734)

Is Riken Keiki (TSE:7734) A Risky Investment?

Jul 23
Is Riken Keiki (TSE:7734) A Risky Investment?

Riken Keiki (TSE:7734) Is Looking To Continue Growing Its Returns On Capital

Jul 04
Riken Keiki (TSE:7734) Is Looking To Continue Growing Its Returns On Capital

Riken Keiki Co., Ltd.'s (TSE:7734) Price In Tune With Earnings

May 02
Riken Keiki Co., Ltd.'s (TSE:7734) Price In Tune With Earnings

Estimating The Fair Value Of Riken Keiki Co., Ltd. (TSE:7734)

Apr 17
Estimating The Fair Value Of Riken Keiki Co., Ltd. (TSE:7734)

Riken Keiki (TSE:7734) Is Paying Out A Dividend Of ¥40.00

Mar 03
Riken Keiki (TSE:7734) Is Paying Out A Dividend Of ¥40.00

Winst- en omzetgroeiprognoses

TSE:7734 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (JPY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
3/31/202756,81012,11511,008N/A2
3/31/202653,04010,93010,523N/A2
3/31/202548,1169,3759,872N/A2
6/30/202445,3348,084N/AN/AN/A
3/31/202445,5818,378-4162,218N/A
12/31/202344,5618,118N/AN/AN/A
9/30/202345,2758,6724,1565,430N/A
6/30/202345,7318,622N/AN/AN/A
3/31/202345,0048,6703,5634,572N/A
12/31/202244,2228,255N/AN/AN/A
9/30/202241,4897,3423,2353,848N/A
6/30/202239,0887,078N/AN/AN/A
3/31/202237,3635,9638,2089,034N/A
12/31/202136,7376,454N/AN/AN/A
9/30/202135,1305,8565,7967,176N/A
6/30/202133,5585,161N/AN/AN/A
3/31/202132,2094,6911,3014,085N/A
12/31/202031,7074,106N/AN/AN/A
9/30/202031,4283,9731,0495,428N/A
6/30/202031,9714,157N/AN/AN/A
3/31/202032,1894,3421,1805,232N/A
12/31/201931,1003,744N/AN/AN/A
9/30/201931,1353,7891,6993,726N/A
6/30/201931,0374,186N/AN/AN/A
3/31/201930,6504,0993,3944,220N/A
12/31/201830,9454,474N/AN/AN/A
9/30/201830,0204,3012,8483,809N/A
6/30/201829,1213,692N/AN/AN/A
3/31/201828,0893,174N/A3,373N/A
12/31/201727,2614,469N/AN/AN/A
9/30/201726,0704,511N/A3,832N/A
6/30/201724,5924,251N/AN/AN/A
3/31/201723,3574,127N/A4,137N/A
12/31/201623,1262,358N/AN/AN/A
9/30/201623,3912,359N/A3,545N/A
6/30/201623,3552,433N/AN/AN/A
3/31/201623,4172,574N/A3,460N/A
12/31/201522,9062,744N/AN/AN/A
9/30/201522,2072,741N/A2,921N/A
6/30/201521,9312,830N/AN/AN/A
3/31/201521,3352,693N/A2,410N/A
12/31/201421,2242,922N/AN/AN/A
9/30/201420,8222,637N/A2,467N/A
6/30/201420,4732,389N/AN/AN/A
3/31/201420,1802,314N/A3,066N/A
12/31/201320,0282,477N/AN/AN/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 7734's forecast earnings growth (14.5% per year) is above the savings rate (0.3%).

Winst versus markt: 7734's earnings (14.5% per year) are forecast to grow faster than the JP market (8.9% per year).

Hoge groeiwinsten: 7734's earnings are forecast to grow, but not significantly.

Omzet versus markt: 7734's revenue (8.4% per year) is forecast to grow faster than the JP market (4.2% per year).

Hoge groei-inkomsten: 7734's revenue (8.4% per year) is forecast to grow slower than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: 7734's Return on Equity is forecast to be low in 3 years time (14.2%).


Ontdek groeibedrijven